SCHEMBL18926487

SCHEMBL18926487

COC1CCC(C2(c3cc(NC(=O)c4ccc(Cl)cn4)ccc3C)N=C(C)C(N)=N2)CC1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.65
APP P05067 9/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18927139 0.91 BACE1 (0.67) BACE1APP
SCHEMBL21654466 0.91 BACE1 (0.66) BACE1APP
SCHEMBL18926394 0.90 BACE1 (0.66) BACE1APP
SCHEMBL932487 0.86 BACE1 (0.60) BACE1APP
SCHEMBL18927146 0.85 BACE1 (0.66) BACE1APP
SCHEMBL21654465 0.83 BACE1 (0.70) BACE1APP
SCHEMBL931202 0.80 BACE1 (0.59) BACE1APP
SCHEMBL21654372 0.80 BACE1 (0.65) BACE1APP
SCHEMBL9948169 0.79 BACE1 (1.00) BACE1APP
SCHEMBL9948016 0.79 BACE1 (1.00) BACE1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-B1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS ASTRAZENECA AB (SE) 2020-01-29 EP disclosed
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 EP disclosed